KZR vs VRTX: Which Stock is Better?
Side-by-side comparison of Kezar Life Sciences Inc and Vertex Pharmaceuticals Inc in 2026
KZR
Kezar Life Sciences Inc
$7.33
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | KZR | VRTX | Winner |
|---|---|---|---|
| Market Cap | $54.33M | $110.81B | VRTX |
| P/E Ratio | N/A | 28.42 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 0.0% | 53.7% | VRTX |
Analyze KZR
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KZR or VRTX a better investment?
Comparing KZR and VRTX: Kezar Life Sciences Inc has a market cap of $54.33M while Vertex Pharmaceuticals Inc has $110.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KZR and VRTX?
KZR (Kezar Life Sciences Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KZR or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KZR or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for KZR.
Which company is more profitable: KZR or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for KZR.
Which is the larger company: KZR or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.81B compared to $54.33M for KZR.
Should I buy KZR or VRTX in 2026?
Both KZR and VRTX have investment merit. KZR trades at $7.33 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KZR and VRTX stock?
Key differences: Market Cap ($54.33M vs $110.81B), P/E Ratio (N/A vs 28.4x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).